Ignite Creation Date:
2024-05-06 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05199051
Status:
RECRUITING
Last Update Posted:
2023-11-13
First Post:
2021-11-12
Brief Title:
A Phase 2 Study of Gemtuzumab Ozogamicin GO-Gilteritinib Combination in Adults With FLT3-ITD RelapseRefractory RR AML
Sponsor:
Organization:
Centre Antoine Lacassagne